Goldman Sachs Group »

Rapt Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 374k 3.05
2024-03-31 $1.7M 186k 8.98
2023-12-31 $4.9M 196k 24.85
2023-09-30 $3.0M 178k 16.62
2023-06-30 $3.5M 188k 18.70
2023-03-31 $3.2M 174k 18.35
2022-12-31 $3.9M 198k 19.80
2022-06-30 $511k 28k 18.27
2022-03-31 $1.1M 51k 21.98
2021-12-31 $1.3M 36k 36.74
2021-09-30 $981k 32k 31.08
2021-03-31 $227k 10k 22.16
2020-12-31 $326k 17k 19.74
2020-06-30 $2.6M 88k 29.02